Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease

Brain Research

Volumn 1068, Issue 1, 2006, Pages 221-229

  Kanaan, Nicholas M ^a   Collier, Timothy J ^b   Marchionini, Deanna M ^a   McGuire, Susan O ^c   Fleming, Matthew F ^d   Sortwell, Caryl E ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d NONE

Author keywords

6 OHDA; Erythropoietin; Graft survival; Parkinson's disease; Transplantation; Ventral mesencephalon

Indexed keywords

ERYTHROPOIETIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; MALE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; DOPAMINE; ERYTHROPOIETIN, RECOMBINANT; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PERFUSION; PHENOTYPE; RATS; RATS, INBRED F344; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RODENTIA;

EID: 31344465984     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.10.078     Document Type: Article

References (58)

1. M. Abercrombie Estimation of nuclear populations from microtome sections Anat. Rec. 94 1946 239 247
2. D. Agnello, P. Bigini, P. Villa, T. Mennini, A. Cerami, M.L. Brines, and P. Ghezzi Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis Brain Res. 952 2002 128 134
3. J. Altman, and S.A. Bayer Development of the brain stem in the rat. V. Thymidine-radiographic study of the time of origin of neurons in the midbrain tegmentum J. Comp. Neurol. 198 1981 677 716
4. R.A. Barker, S.B. Dunnett, A. Faissner, and J.W. Fawcett The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum Exp. Neurol. 141 1996 79 93
5. M. Bernaudin, H.H. Marti, S. Roussel, D. Divoux, A. Nouvelot, E.T. MacKenzie, and E. Petit A potential role for erythropoietin in focal permanent cerebral ischemia in mice J. Cereb. Blood Flow Metab. 19 1999 643 651
6. M. Brines, and A. Cerami Emerging biological roles for erythropoietin in the nervous system Nat. Rev., Neurosci. 6 2005 484 494
7. P. Brundin, R.E. Strecker, O. Lindvall, O. Isacson, O.G. Nilsson, G. Barbin, A. Prochiantz, C. Forni, A. Nieoullon, and H. Widner Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease Ann. N. Y. Acad. Sci. 495 1987 473 496
8. P. Brundin, J. Karlsson, M. Emgard, G.S. Schierle, O. Hansson, A. Petersen, and R.F. Castilho Improving the survival of grafted dopaminergic neurons: a review over current approaches Cell Transplant 9 2000 179 195
9. G. Calapai, M.C. Marciano, F. Corica, A. Allegra, A. Parisi, N. Frisina, A.P. Caputi, and M. Buemi Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation Eur. J. Pharmacol. 401 2000 349 356
10. M. Celik, N. Gokmen, S. Erbayraktar, M. Akhisaroglu, S. Konakc, C. Ulukus, S. Genc, K. Genc, E. Sagiroglu, A. Cerami, and M. Brines Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc. Natl. Acad. Sci. U. S. A. 99 2002 2258 2263
11. E.Y. Chen, E. Kallwitz, S.E. Leff, E.J. Cochran, E.J. Mufson, J.H. Kordower, and R.J. Mandel Age-related decreases in GTP-cyclohydrolase-I immunoreactive neurons in the monkey and human substantia nigra J. Comp. Neurol. 426 2000 534 548
12. Z.Z. Chong, J.Q. Kang, and K. Maiese Erythropoietin: cytoprotection in vascular and neuronal cells Curr. Drug Targets. Cardiovasc. Haematol. Disord. 3 2003 141 154
13. Y. Chu, K. Kompoliti, E.J. Cochran, E.J. Mufson, and J.H. Kordower Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra J. Comp. Neurol. 450 2002 203 214
14. T.J. Collier, C.E. Sortwell, and B.F. Daley Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation J. Neurosci. 19 1999 5563 5573
15. T.J. Collier, K. Steece-Collier, S. McGuire, and C.E. Sortwell Cellular models to study dopaminergic injury responses Ann. N. Y. Acad. Sci. 991 2003 140 151
16. T.J. Collier, L.Z. Dung, P.M. Carvey, A. Fletcher-Turner, D.M. Yurek, J.R. Sladek Jr., and J.H. Kordower Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism Exp. Neurol. 191 Suppl. 1 2005 S60 S67
17. T.J. Collier, C.E. Sortwell, M.F. Fleming, D.M. Marchionini, N.M. Kanaan, K. Steece-Collier, and S. McGuire Inhibition of microglial activation by minocycline treatment enhances survival of grafted embryonic dopamine neurons Tenth Annual Conference of the American Society for Neural Transplantation and Repair Abstracts Exp. Neurol. vol. 181 2005 84 112
18. M. Csete, L. Rodriguez, M. Wilcox, and S. Chadalavada Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts Neurosci. Lett. 359 2004 124 126
19. M. Digicaylioglu, S. Bichet, H.H. Marti, R.H. Wenger, L.A. Rivas, C. Bauer, and M. Gassmann Localization of specific erythropoietin binding sites in defined areas of the mouse brain Proc. Natl. Acad. Sci. U. S. A. 92 1995 3717 3720
20. M.E. Emborg, S.Y. Ma, E.J. Mufson, A.I. Levey, M.D. Taylor, W.D. Brown, J.E. Holden, and J.H. Kordower Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys J. Comp. Neurol. 401 1998 253 265
21. M. Emgard, J. Karlsson, O. Hansson, and P. Brundin Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts Exp. Neurol. 160 1999 279 288
22. J.W. Fawcett, R.A. Barker, and S.B. Dunnett Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon Exp. Brain Res. 106 1995 275 282
23. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 Pt. 5 1991 2283 2301
24. S. Genc, F. Kuralay, K. Genc, M. Akhisaroglu, S. Fadiloglu, K. Yorukoglu, M. Fadiloglu, and A. Gure Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production Neurosci. Lett. 298 2001 139 141
25. S. Genc, M. Akhisaroglu, F. Kuralay, and K. Genc Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine- induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro Neurosci. Lett. 321 2002 73 76
26. G.A. Gerhardt, W.A. Cass, A. Yi, Z. Zhang, and D.M. Gash Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys J. Neurochem. 80 2002 168 177
27. O. Hornykiewicz Neurochemical pathology and the etiology of Parkinson's disease: basic facts and hypothetical possibilities Mt. Sinai J. Med. 55 1988 11 20
28. Y. Huh, C. Kim, J. Cho, W. Lee, J. Kim, and H. Ahn Differential effects of aging on NADPH-diaphorase and VIP neurons in cerebral cortex of rats NeuroReport 8 1997 2991 2994
29. A.K. Junk, A. Mammis, S.I. Savitz, M. Singh, S. Roth, S. Malhotra, P.S. Rosenbaum, A. Cerami, M. Brines, and D.M. Rosenbaum Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury Proc. Natl. Acad. Sci. U. S. A. 99 2002 10659 10664
30. S.E. Juul, D.K. Anderson, Y. Li, and R.D. Christensen Erythropoietin and erythropoietin receptor in the developing human central nervous system Pediatr. Res. 43 1998 40 49
31. S.E. Juul, A.T. Yachnis, A.M. Rojiani, and R.D. Christensen Immunohistochemical localization of erythropoietin and its receptor in the developing human brain Pediatr. Dev. Pathol. 2 1999 148 158
32. P.A. Kaseloo, A. Lis, H. Asada, T.A. Barone, and R.J. Plunkett In vitro assessment of neurotrophic activity from the striatum of aging rats Neurosci. Lett. 218 1996 157 160
33. T. Kawamata, S. Nakamura, I. Akiguchi, J. Kimura, M. Kameyama, H. Kimura, and T. Takeda Effect of aging on NADPH-diaphorase neurons in laterodorsal tegmental nucleus and striatum of mice Neurobiol. Aging 11 1990 185 192
34. J.H. Kordower, J.M. Rosenstein, T.J. Collier, M.A. Burke, E.Y. Chen, J.M. Li, L. Martel, A.E. Levey, E.J. Mufson, T.B. Freeman, and C.W. Olanow Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies J. Comp. Neurol. 370 1996 203 230
35. P. Lewczuk, M. Hasselblatt, H. Kamrowski-Kruck, A. Heyer, C. Unzicker, A.L. Siren, and H. Ehrenreich Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin NeuroReport 11 2000 3485 3488
36. W. Li, Y. Maeda, R.R. Yuan, S. Elkabes, S. Cook, and P. Dowling Beneficial effect of erythropoietin on experimental allergic encephalomyelitis Ann. Neurol. 56 2004 767 777
37. Z.D. Ling, T.J. Collier, C.E. Sortwell, J.W. Lipton, T.Q. Vu, H.C. Robie, and P.M. Carvey Striatal trophic activity is reduced in the aged rat brain Brain Res. 856 2000 301 309
38. T.J. Mahalik, W.E. Hahn, G.H. Clayton, and G.P. Owens Programmed cell death in developing grafts of fetal substantia nigra Exp. Neurol. 129 1994 27 36
39. D.M. Marchionini, T.J. Collier, M. Camargo, S. McGuire, M. Pitzer, and C.E. Sortwell Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease J. Comp. Neurol. 464 2003 172 179
40. D.M. Marchionini, T.J. Collier, M.R. Pitzer, and C.E. Sortwell Reassessment of caspase inhibition to augment grafted dopamine neuron survival Cell Transplant 13 2004 273 282
41. H.H. Marti, M. Bernaudin, E. Petit, and C. Bauer Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia News Physiol. Sci. 15 2000 225 229
42. M.M. Mesulam, E.J. Mufson, and J. Rogers Age-related shrinkage of cortically projecting cholinergic neurons: a selective effect Ann. Neurol. 22 1987 31 36
43. R. Riddle, and J.D. Pollock Making connections: the development of mesencephalic dopaminergic neurons Brain Res. Dev. Brain Res. 147 2003 3 21
44. Y. Sadamoto, K. Igase, M. Sakanaka, K. Sato, H. Otsuka, S. Sakaki, S. Masuda, and R. Sasaki Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery Biochem. Biophys. Res. Commun. 253 1998 26 32
45. M. Sakanaka, T.C. Wen, S. Matsuda, S. Masuda, E. Morishita, M. Nagao, and R. Sasaki In vivo evidence that erythropoietin protects neurons from ischemic damage Proc. Natl. Acad. Sci. U. S. A. 95 1998 4635 4640
46. K. Sawamoto, N. Nakao, K. Kakishita, Y. Ogawa, Y. Toyama, A. Yamamoto, M. Yamaguchi, K. Mori, S.A. Goldman, T. Itakura, and H. Okano Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene J. Neurosci. 21 2001 3895 3903
47. M. Silva, A. Benito, C. Sanz, F. Prosper, D. Ekhterae, G. Nunez, and J.L. Fernandez-Luna Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines J. Biol. Chem. 274 1999 22165 22169
48. H.H. Simon, L. Bhatt, D. Gherbassi, P. Sgado, and L. Alberi Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors Ann. N. Y. Acad. Sci. 991 2003 36 47
49. S.R. Sinclair, J.W. Fawcett, and S.B. Dunnett Dopamine cells in nigral grafts differentiate prior to implantation Eur. J. Neurosci. 11 1999 4341 4348
50. C.E. Sortwell Strategies for the augmentation of grafted dopamine neuron survival Front. Biosci. 8 2003 s522 s532
51. C.E. Sortwell, T.J. Collier, and J.R. Sladek Jr. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons J. Comp. Neurol. 399 1998 530 540
52. C.E. Sortwell, M.R. Pitzer, and T.J. Collier Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival Exp. Neurol. 165 2000 268 277
53. C.E. Sortwell, M.D. Camargo, M.R. Pitzer, S. Gyawali, and T.J. Collier Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval Exp. Neurol. 169 2001 23 29
54. C.E. Sortwell, T.J. Collier, M.D. Camargo, and M.R. Pitzer An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality Exp. Neurol. 187 2004 58 64
55. L. Studer, M. Csete, S.H. Lee, N. Kabbani, J. Walikonis, B. Wold, and R. McKay Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen J. Neurosci. 20 2000 7377 7383
56. T. Takeshima, K. Shimoda, J.M. Johnston, and J.W. Commissiong Standardized methods to bioassay neurotrophic factors for dopaminergic neurons J. Neurosci. Methods 67 1996 27 41
57. P. Villa, P. Bigini, T. Mennini, D. Agnello, T. Laragione, A. Cagnotto, B. Viviani, M. Marinovich, A. Cerami, T.R. Coleman, M. Brines, and P. Ghezzi Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis J. Exp. Med. 198 2003 971 975
58. W.M. Zawada, D.J. Zastrow, E.D. Clarkson, F.S. Adams, K.P. Bell, and C.R. Freed Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats Brain Res. 786 1998 96 103